Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)

1.70
Delayed Data
As of Dec 02
 -0.03 / -1.73%
Today’s Change
1.57
Today|||52-Week Range
64.38
-92.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$8.5M

Company Description

Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company engaged in the development of therapeutic products for the treatment of rare and orphan diseases. The company was founded on March 5, 2018 and is headquartered in Kefar Sava, Israel.

Contact Information

Quoin Pharmaceuticals Ltd.
23 Hata'as Street
Kefar Sava Tel Aviv 44425
P:
Investor Relations:

Employees

Shareholders

Other institutional2.49%
Mutual fund holders0.02%
Individual stakeholders--

Top Executives

Michael MyersChairman & Chief Executive Officer
Denise CarterChief Operating Officer & Director
Gordon B. DunnChief Financial Officer